ArticleChemistry & biodiversity2026
Optimization of Antioxidant Flavonoids Extraction From Helianthus annuus L. Ray Florets for Cardioprotective Nutraceuticals.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The aim of this study was to investigate the ultrasound-assisted extraction (UAE) of antioxidant flavonoids from sunflower (Helianthus annuus) ray florets through the optimization of the parameters (temperature, extraction ratio, and solvent concentration) using a response surface methodology (RSM), then to validate the model conducting wet-lab analyses, and finally, to characterize the optimized extracts for composition and in vitro cardioprotective potential. Within RSM, the parameters of UAE were optimized by maximization of the response variables yield of flavonoid extraction and Trolox equivalent antioxidant capacity. Two optimal solutions obtained in 73% ethanol, at 30:1 (v/w) extraction ratio and 80°C (extract 1') and in 77% ethanol, at 12:1 (v/w) extraction ratio and 40°C (extract 2') were validated. HPLC analysis revealed that rutin and myricetin were the main flavonoids in both optimized extracts and slightly higher amounts were quantified in extract 2'. In addition, extract 2' presented higher free radical scavenging activity and angiotensin-converting enzyme (ACE) inhibition than extract 1'. Both extracts were cytocompatible in an endothelial cell culture, in a wide range of concentrations (31.25-500 µg/mL) and stimulated the cell metabolism, after 24 h of cultivation. Optimized extract 2' containing flavonoids from sunflower ray florets with antioxidant properties and cardioprotective potential was also a solution of interest for the bioeconomy, due to less consuming extraction conditions. This extract could be recommended for further testing as a valuable ingredient of novel cardioprotective nutraceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.